Strengthening radon surveillance in British Columbia: Insights from a qualitative evaluation of the British Columbia Radon Data Repository
Canada Communicable Disease Report · 31.07.2026 · 52 (7/8) · 282-289
DOI: 10.14745/ccdr.v52i78a03 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canada Communicable Disease Report, online erschienen am 31.07.2026. Verfasst von Bridget Irwin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Canadian Field Epidemiology Program, Centre for Emergency Preparedness, Regulatory, Operations and Emergency Management Branch, Public Health Agency …. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Canadian Field Epidemiology Program, Centre for Emergency Preparedness, Regulatory, Operations and Emergency Management Branch, Public Health Agency of Canada, Ottawa, ON.
- Environmental Health Services, British Columbia Centre for Disease Control, Vancouver, BC.
- School of Population and Public Health, University of British Columbia, Vancouver, BC.
Zitieren
APA
Irwin, B., Yao, J. A., & McVea, D. (2026). Strengthening radon surveillance in British Columbia: Insights from a qualitative evaluation of the British Columbia Radon Data Repository. Canada Communicable Disease Report, 52(7/8), 282-289. https://doi.org/10.14745/ccdr.v52i78a03
Vancouver
Irwin B, Yao JA, McVea D. Strengthening radon surveillance in British Columbia: Insights from a qualitative evaluation of the British Columbia Radon Data Repository. Canada Communicable Disease Report. 2026;52(7/8):282-289. doi:10.14745/ccdr.v52i78a03
BibTeX
@article{Irwin2026,
author = {Irwin, Bridget and Yao, Jiayun Angela and McVea, David},
title = {Strengthening radon surveillance in British Columbia: Insights from a qualitative evaluation of the British Columbia Radon Data Repository},
journal = {Canada Communicable Disease Report},
year = {2026},
volume = {52},
number = {7/8},
pages = {282--289},
doi = {10.14745/ccdr.v52i78a03}
}
EUVIMED